South Korea Radiopharmaceutical Market Outlook | Share, Trends, Value, Revenue, Size, Analysis, Forecast, COVID-19 IMPACT, Industry, Companies & Growth

Market Forecast By Types (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), By Applications (Diagnostic Applications, Therapeutic Applications), By Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures), By Source (Nuclear Reactors, Cyclotrons), By End-users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others) And Competitive Landscape

Product Code: ETC088662 Publication Date: Jun 2021 Updated Date: Jun 2026 Product Type: Report
Publisher: 6Wresearch Author: Ravi Bhandari No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

South Korea Radiopharmaceutical Market Size, Share & Growth Rate

The South Korea Radiopharmaceutical Market was estimated at USD 407 Million in 2025 and is projected to reach USD 535 Million by 2032, growing at a CAGR of 4.0% from 2026 to 2032. This trajectory is driven by a growing aging population, increased incidences of cancer, and heightened investments in advanced nuclear medicine technologies. Additionally, the robust development of healthcare infrastructure, along with rising demand for precise diagnostic and therapeutic procedures, is expected to fuel market growth.

South Korea Radiopharmaceutical Market Growth Rate Analysis (2021-2032)

The South Korean radiopharmaceutical market has displayed stable, yet gradually decelerating growth, with rates of 5.0% in 2021 and 4.8% in 2022, tapering to 4.6% in 2023 and 2024. This trend is mainly attributed to consistent investments in advanced nuclear medicine technology, alongside rising consumer demand for precision diagnostics in oncology. The market is expected to reach a growth rate of 4.9% by 2029 and 4.8% in 2032, showcasing resilience amidst fluctuating healthcare priorities and regulatory frameworks. Enhancements in distribution infrastructure and a focus on sustainable energy solutions also play a vital role in supporting this sector's performance, ensuring a robust response to evolving healthcare challenges.

South Korea Radiopharmaceutical Market Year-wise Growth Rate and Key Drivers

This graph highlights how the South Korea Radiopharmaceutical Market has steadily grown over the past five years, supported by major growth factors.

South Korea Radiopharmaceutical Market Year-wise Growth Rate and Key Drivers

The table below presents the year‑wise growth rates along with the key drivers influencing the market

YearGrowth RateMajor Drivers
20215.0%Improved nuclear medicine facilities boosted radiopharmaceutical production capacities
20224.8%Modernized radiopharmaceutical manufacturing facilities boost production efficiency significantly
20234.6%Manufacturing investments in advanced radiopharmaceutical facilities drive capacity growth
20244.5%New radiopharmaceutical manufacturing facilities boost production capacity utilization
20254.6%Health sector investments boost radiopharmaceutical production capacity in facilities
20264.5%Domestic radiopharmaceutical manufacturing investments boost supply chain resilience
20274.6%Strengthened nuclear medicine usage boosted radiopharmaceutical production capacity
20284.4%Domestic radiopharmaceutical manufacturers boost capacity through advanced equipment investments
20294.9%Radiopharmaceutical manufacturing automation boosts production efficiency and capacity
20304.9%State funded research initiatives boost domestic radiopharmaceutical manufacturing capabilities
20314.7%Increased production of radioisotopes boosted local healthcare supply chains
20324.8%Improved radiation therapy technologies increased demand for isotope production

Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.

South Korea Radiopharmaceutical Market Synopsis

Recent momentum in the South Korea Radiopharmaceutical Market has been characterized by significant advancements in imaging technologies and expanding applications in cancer treatment. Looking forward, the market is poised for a transformative phase, as innovations in radiopharmaceutical compounds and an emphasis on personalized medicine reshape the landscape.

While the market is experiencing healthy growth, challenges related to regulatory hurdles and the high costs associated with research and development remain prevalent. Nevertheless, the commitment to enhancing patient care through innovative radiopharmaceutical solutions signifies a promising outlook for stakeholders.

South Korea Radiopharmaceutical Market Key Takeaways

  • The South Korea Radiopharmaceutical Market is projected to grow steadily, with significant opportunities arising from technological advancements.
  • Increased focus on early cancer detection and treatment drives demand for radiopharmaceuticals.
  • Government initiatives and funding are enhancing research capabilities and market accessibility.
  • Emerging applications in targeted therapies suggest a diversification of product offerings in the coming years.
  • Strategic partnerships and collaborations within the healthcare sector are expected to bolster market growth.

Evaluation of Restraints in South Korea Radiopharmaceutical Market

Several factors pose constraints to the growth of the South Korea Radiopharmaceutical Market. High production costs associated with radiopharmaceuticals can limit accessibility and affordability for healthcare providers and patients alike. Moreover, the regulatory landscape surrounding the approval and commercialization of new radiopharmaceutical agents can be complex and time-consuming, potentially delaying product availability. Additionally, the need for specialized handling and storage of radiopharmaceuticals may deter smaller healthcare facilities from integrating these technologies into their practice.

South Korea Radiopharmaceutical Market Trends

The South Korea Radiopharmaceutical Market is witnessing notable trends such as a shift towards targeted therapies that utilize radiopharmaceuticals for more effective treatment of malignancies. Furthermore, there is an increasing integration of artificial intelligence and machine learning technologies in diagnostic imaging, which enhances precision in patient outcomes. The rise of outpatient imaging services also signifies a change in patient care dynamics, promoting the use of radiopharmaceuticals in more accessible settings.

South Korea Radiopharmaceutical Market Opportunities

The opportunities within the South Korea Radiopharmaceutical Market are abundant, particularly in expanding applications in therapeutic areas beyond oncology. Innovations in radiolabeled compounds for cardiac and neurological disorders are gaining traction. Furthermore, ongoing research into novel radionuclide therapies presents significant potential for new product developments. Collaborations between academic institutions and industry stakeholders are set to yield ground-breaking advancements, providing lucrative investment avenues.

Government Initiatives in the South Korea Radiopharmaceutical Market

The South Korean government has actively supported the radiopharmaceutical sector through various initiatives aimed at boosting research and development. Programs aimed at enhancing the production capabilities of domestic radiopharmaceutical manufacturers have been introduced, alongside funding for innovative healthcare technologies. Regulatory bodies are also working to streamline approval processes, thereby facilitating quicker access to market for new products and improving overall patient care.

Future Insights of the South Korea Radiopharmaceutical Market

Looking ahead to the period of 2026-2032, the South Korea Radiopharmaceutical Market is set to experience transformative changes driven by continuous technological advancements and evolving healthcare needs. As more research uncovers novel applications for radiopharmaceuticals, particularly in personalized medicine, we can anticipate an expansion in treatment options available to clinicians. This evolution is likely to foster enhanced patient outcomes, making radiopharmaceuticals a cornerstone of modern medical practices in South Korea.

South Korea Radiopharmaceutical Market Latest Developments (May 2025 - June 2026)

Recent developments in the South Korea Radiopharmaceutical Market indicate a growing trend towards the introduction of innovative diagnostic agents. Research initiatives are increasingly focusing on the development of hybrid imaging technologies that combine the strengths of different modalities, enhancing diagnostic capabilities. Additionally, collaborations between leading research institutions and healthcare providers are paving the way for clinical trials aimed at evaluating novel radiopharmaceuticals for a variety of therapeutic applications.

South Korea Radiopharmaceutical Market - Key Attractiveness of the Report

  • 10 Years of Market Numbers
  • Historical Data Starting from 2022 to 2025
  • Base Year: 2025
  • Forecast Data until 2032
  • Key Performance Indicators Impacting the Market
  • Major Upcoming Developments and Projects

Key Highlights of the Report:

  • South Korea Radiopharmaceutical Market Outlook
  • Market Size of South Korea Radiopharmaceutical Market, 2025
  • Forecast of South Korea Radiopharmaceutical Market, 2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Revenues & Volume for the Period 2022-2032F
  • South Korea Radiopharmaceutical Market Trend Evolution
  • South Korea Radiopharmaceutical Market Drivers and Challenges
  • South Korea Radiopharmaceutical Price Trends
  • South Korea Radiopharmaceutical Porter's Five Forces
  • South Korea Radiopharmaceutical Industry Life Cycle
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Types for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Diagnostic Nuclear Medicine for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Therapeutic Nuclear Medicine for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Applications for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Diagnostic Applications for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Therapeutic Applications for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Procedural Volume Assessment for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Diagnostic Procedures for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Therapeutic Procedures for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Source for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Nuclear Reactors for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Cyclotrons for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By End-users for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Hospitals for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Ambulatory Surgical Centers for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Diagnostic Centers for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Cancer Research Institutes for the Period 2022-2032F
  • Historical Data and Forecast of South Korea Radiopharmaceutical Market Revenues & Volume By Others for the Period 2022-2032F
  • South Korea Radiopharmaceutical Import Export Trade Statistics
  • Market Opportunity Assessment By Types
  • Market Opportunity Assessment By Applications
  • Market Opportunity Assessment By Procedural Volume Assessment
  • Market Opportunity Assessment By Source
  • Market Opportunity Assessment By End-users
  • South Korea Radiopharmaceutical Top Companies Market Share
  • South Korea Radiopharmaceutical Competitive Benchmarking By Technical and Operational Parameters
  • South Korea Radiopharmaceutical Company Profiles
  • South Korea Radiopharmaceutical Key Strategic Recommendations

South Korea Radiopharmaceutical Market - Frequently Asked Questions

The market is estimated at USD 407 Million in 2025 and projected to reach USD 535 Million by 2032, with a growth rate of 4.0% CAGR from 2026 to 2032. This indicates a robust upward trajectory fueled by increased demand for advanced medical diagnostics.
The primary applications driving demand include oncology diagnostics and therapeutics, as well as emerging uses in cardiology and neurology. The push towards precision medicine is increasingly influencing these trends.
Yes, the South Korean government is actively supporting the sector through funding programs aimed at enhancing research capabilities and streamlining regulatory processes for the approval of new radiopharmaceuticals.
Technology is pivotal; advancements in imaging techniques and the integration of AI in diagnostic procedures are significantly enhancing the effectiveness and precision of radiopharmaceuticals in clinical applications.
High production costs and complex regulatory frameworks may act as barriers to the widespread adoption of new radiopharmaceutical products. Addressing these issues will be crucial for maintaining the market's growth trajectory.
6Wresearch actively monitors the South Korea Radiopharmaceutical Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the South Korea Radiopharmaceutical Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 South Korea Radiopharmaceutical Market Overview

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Radiopharmaceutical Market Revenues & Volume, 2022 & 2032F

3.3 South Korea Radiopharmaceutical Market - Industry Life Cycle

3.4 South Korea Radiopharmaceutical Market - Porter's Five Forces

3.5 South Korea Radiopharmaceutical Market Revenues & Volume Share, By Types, 2022 & 2032F

3.6 South Korea Radiopharmaceutical Market Revenues & Volume Share, By Applications, 2022 & 2032F

3.7 South Korea Radiopharmaceutical Market Revenues & Volume Share, By Procedural Volume Assessment, 2022 & 2032F

3.8 South Korea Radiopharmaceutical Market Revenues & Volume Share, By Source, 2022 & 2032F

3.9 South Korea Radiopharmaceutical Market Revenues & Volume Share, By End-users, 2022 & 2032F

4 South Korea Radiopharmaceutical Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer and cardiovascular diseases in South Korea

4.2.2 Growing adoption of nuclear medicine for diagnosis and treatment

4.2.3 Technological advancements in radiopharmaceuticals

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for radiopharmaceutical production and distribution

4.3.2 High costs associated with development and manufacturing of radiopharmaceuticals

5 South Korea Radiopharmaceutical Market Trends

6 South Korea Radiopharmaceutical Market, By Types

6.1 South Korea Radiopharmaceutical Market, By Types

6.1.1 Overview and Analysis

6.1.2 South Korea Radiopharmaceutical Market Revenues & Volume, By Types, 2022-2032F

6.1.3 South Korea Radiopharmaceutical Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2022-2032F

6.1.4 South Korea Radiopharmaceutical Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2022-2032F

6.2 South Korea Radiopharmaceutical Market, By Applications

6.2.1 Overview and Analysis

6.2.2 South Korea Radiopharmaceutical Market Revenues & Volume, By Diagnostic Applications, 2022-2032F

6.2.3 South Korea Radiopharmaceutical Market Revenues & Volume, By Therapeutic Applications, 2022-2032F

6.3 South Korea Radiopharmaceutical Market, By Procedural Volume Assessment

6.3.1 Overview and Analysis

6.3.2 South Korea Radiopharmaceutical Market Revenues & Volume, By Diagnostic Procedures, 2022-2032F

6.3.3 South Korea Radiopharmaceutical Market Revenues & Volume, By Therapeutic Procedures, 2022-2032F

6.4 South Korea Radiopharmaceutical Market, By Source

6.4.1 Overview and Analysis

6.4.2 South Korea Radiopharmaceutical Market Revenues & Volume, By Nuclear Reactors, 2022-2032F

6.4.3 South Korea Radiopharmaceutical Market Revenues & Volume, By Cyclotrons, 2022-2032F

6.5 South Korea Radiopharmaceutical Market, By End-users

6.5.1 Overview and Analysis

6.5.2 South Korea Radiopharmaceutical Market Revenues & Volume, By Hospitals, 2022-2032F

6.5.3 South Korea Radiopharmaceutical Market Revenues & Volume, By Ambulatory Surgical Centers, 2022-2032F

6.5.4 South Korea Radiopharmaceutical Market Revenues & Volume, By Diagnostic Centers, 2022-2032F

6.5.5 South Korea Radiopharmaceutical Market Revenues & Volume, By Cancer Research Institutes, 2022-2032F

6.5.6 South Korea Radiopharmaceutical Market Revenues & Volume, By Others, 2022-2032F

7 South Korea Radiopharmaceutical Market Import-Export Trade Statistics

7.1 South Korea Radiopharmaceutical Market Export to Major Countries

7.2 South Korea Radiopharmaceutical Market Imports from Major Countries

8 South Korea Radiopharmaceutical Market Key Performance Indicators

8.1 Number of nuclear medicine procedures performed annually

8.2 Investment in research and development for radiopharmaceuticals

8.3 Adoption rate of new radiopharmaceutical technologies

8.4 Number of partnerships or collaborations in the radiopharmaceutical industry

8.5 Patient satisfaction and outcomes related to radiopharmaceutical usage

9 South Korea Radiopharmaceutical Market - Opportunity Assessment

9.1 South Korea Radiopharmaceutical Market Opportunity Assessment, By Types, 2022 & 2032F

9.2 South Korea Radiopharmaceutical Market Opportunity Assessment, By Applications, 2022 & 2032F

9.3 South Korea Radiopharmaceutical Market Opportunity Assessment, By Procedural Volume Assessment, 2022 & 2032F

9.4 South Korea Radiopharmaceutical Market Opportunity Assessment, By Source, 2022 & 2032F

9.5 South Korea Radiopharmaceutical Market Opportunity Assessment, By End-users, 2022 & 2032F

10 South Korea Radiopharmaceutical Market - Competitive Landscape

10.1 South Korea Radiopharmaceutical Market Revenue Share, By Companies, 2025

10.2 South Korea Radiopharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All